Madrigal Pharmaceuticals Inc
(MDGL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -299,512 | -147,541 | -373,630 | -261,436 | -162,696 |
| Depreciation Amortization | 1,562 | 823 | 2,941 | 2,046 | 1,237 |
| Accounts receivable | -6,899 | 0 | N/A | 0 | N/A |
| Accounts payable and accrued liabilities | -19,047 | -11,513 | 4,210 | -7,289 | -6,297 |
| Other Working Capital | -30,458 | -22,341 | -3,276 | -19,790 | -20,141 |
| Other Operating Activity | 70,252 | 31,415 | 45,525 | 42,172 | 28,520 |
| Operating Cash Flow | $-284,102 | $-149,157 | $-324,230 | $-244,297 | $-159,377 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -18,557 | 98,410 | -501,041 | -139,954 | -190,492 |
| PPE Investments | -488 | -357 | -1,479 | -443 | -104 |
| Purchase Sale Intangibles | -5,000 | 0 | N/A | 0 | N/A |
| Other Investing Activity | -5,000 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-24,045 | $98,053 | $-502,520 | $-140,397 | $-190,596 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 65,000 | 65,000 | 50,000 |
| Common Stock Issued | 707,829 | 573,706 | 530,479 | 50,563 | 45,908 |
| Other Financing Activity | 0 | 0 | -363 | -363 | -288 |
| Financing Cash Flow | $707,829 | $573,706 | $595,116 | $115,200 | $95,620 |
| Beginning Cash Position | 99,915 | 99,915 | 331,549 | 331,549 | 331,549 |
| End Cash Position | 499,597 | 622,517 | 99,915 | 62,055 | 77,196 |
| Net Cash Flow | $399,682 | $522,602 | $-231,634 | $-269,494 | $-254,353 |
| Free Cash Flow | |||||
| Operating Cash Flow | -284,102 | -149,157 | -324,230 | -244,297 | -159,377 |
| Capital Expenditure | -488 | -357 | -1,479 | -443 | -104 |
| Free Cash Flow | -284,590 | -149,514 | -325,709 | -244,740 | -159,481 |